CLINICAL_TRIALS
trial_result
· 2025-10-15
Clinical Trial Update: POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis [Phase 2]
Summary
A Phase 2 proof-of-concept study evaluating BSI-045B for moderate-to-severe atopic dermatitis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biosion, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-10-15